Export 7 results:
Author Title Type [ Year(Asc)]
Filters: Author is Mooney, Larissa J  [Clear All Filters]
2023
Y. - I. Hser, Mooney, L. J., Baldwin, L. - M., Ober, A., Marsch, L. A., Sherman, S., Matthews, A., Clingan, S., Fei, Z., Zhu, Y., Dopp, A., Curtis, M. E., Osterhage, K. P., Hichborn, E. G., Lin, C., Black, M., Calhoun, S., Holtzer, C. C., Nesin, N., Bouchard, D., Ledgerwood, M., Gehring, M. A., Liu, Y., Ha, N. Ah, Murphy, S. M., Hanano, M., and Saxon, A. J., “Care Coordination between Rural Primary Care and Telemedicine to Expand Medication Treatment for Opioid Use Disorder: Results from a Single-arm, Multisite Feasibility Study”, J Rural Health, 2023.
2022
N. S. Karnik, Marsden, J., McCluskey, C., Boley, R. A., Bradley, K. A., Campbell, C. I., Curtis, M. E., Fiellin, D., Ghitza, U., Hefner, K., Hser, Y. - I., R McHugh, K., McPherson, S. M., Mooney, L. J., Moran, L. M., Murphy, S. M., Schwartz, R. P., Shmueli-Blumberg, D., Shulman, M., Stephens, K. A., Watkins, K. E., Weiss, R. D., and Wu, L. - T., “The Opioid Use Disorder Core Outcomes Set (OUD-COS) for Treatment Research: Findings from a Delphi Consensus Study”, Addiction, vol. 17, no. 9, pp. 2438-2447, 2022.
2017
K. M. Gray, Sonne, S. C., McClure, E. A., Ghitza, U. E., Matthews, A. G., McRae-Clark, A. L., Carroll, K. M., Potter, J. S., Wiest, K., Mooney, L. J., Hasson, A., Walsh, S. L., Lofwall, M. R., Babalonis, S., Lindblad, R. W., Sparenborg, S., Wahle, A., King, J. S., Baker, N. L., Tomko, R. L., Haynes, L. F., Vandrey, R. G., and Levin, F. R., “A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.”, Drug Alcohol Depend, vol. 177, pp. 249-257, 2017.
2016
W. Ling, Hillhouse, M. P., Saxon, A. J., Mooney, L. J., Thomas, C. M., Ang, A., Matthews, A. G., Hasson, A., Annon, J., Sparenborg, S., Liu, D. S., McCormack, J., Church, S., Swafford, W., Drexler, K., Schuman, C., Ross, S., Wiest, K., P Korthuis, T., Lawson, W., Brigham, G. S., Knox, P. C., Dawes, M., and Rotrosen, J., “Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study.”, Addiction, vol. 111, no. 8, pp. 1416-27, 2016.
L. J. Mooney, Hillhouse, M. P., Thomas, C., Ang, A., Sharma, G., Terry, G., Chang, L., Walker, R., Trivedi, M., Croteau, D., Sparenborg, S., and Ling, W., “Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder.”, J Addict Med, vol. 10, no. 4, pp. 236-43, 2016.
2014
E. A. McClure, Sonne, S. C., Winhusen, T., Carroll, K. M., Ghitza, U. E., McRae-Clark, A. L., Matthews, A. G., Sharma, G., Van Veldhuisen, P., Vandrey, R. G., Levin, F. R., Weiss, R. D., Lindblad, R., Allen, C., Mooney, L. J., Haynes, L., Brigham, G. S., Sparenborg, S., Hasson, A. L., and Gray, K. M., “Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network.”, Contemp Clin Trials, vol. 39, no. 2, pp. 211-23, 2014.
2013
L. J. Mooney, Nielsen, S., Saxon, A., Hillhouse, M., Thomas, C., Hasson, A., Stablein, D., McCormack, J., Lindblad, R., and Ling, W., “Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology.”, Contemp Clin Trials, vol. 34, no. 2, pp. 196-204, 2013.